title: [Paraneoplastic neurologic syndromes. 2. Lambert-Eaton myasthenic syndrome. 2) Anti-calcium channel antibody and clinical features].
authors.forename: Y
authors.initials: Y
authors.lastname: Nakao
authors.forename: M
authors.initials: M
authors.lastname: Motomura
authors.forename: A
authors.initials: A
authors.lastname: Suenaga
authors.forename: T
authors.initials: T
authors.lastname: Nakamura
authors.forename: T
authors.initials: T
authors.lastname: Yoshimura
authors.forename: M
authors.initials: M
authors.lastname: Tsujihata
authors.forename: M
authors.initials: M
authors.lastname: Ito
authors.forename: S
authors.initials: S
authors.lastname: Kono
authors.forename: K
authors.initials: K
authors.lastname: Eguchi
mesh_terms: D001323:Autoantibodies / Q000276:immunology*; D015220:Calcium Channels / Q000276:immunology*; D006801:Humans; D015624:Lambert-Eaton Myasthenic Syndrome / Q000276:immunology*; D008875:Middle Aged; D010257:Paraneoplastic Syndromes / Q000276:immunology*
chemical_list: D001323:Autoantibodies; D015220:Calcium Channels